(For your information, not specifically tested on unless
otherwise stated.)
- hs-CRP
- Apolipoproteins(a) and (b)
- U-Curve Phenomenon
- Homocyst(e)ine
- Antioxidants
- Cost of treatment (pharmacoeconomic issues):
| Category |
Definition |
Economic Impact |
| Low Risk |
No CHD, < 2 risk
factors (Primary Prevention) |
Cost is high to prevent single event (> $90,000)
|
| Medium Risk |
No CHD, > or equal to 2 risk factors (Primary Prevention)
|
Costs compare favorably with other forms of medical therapy
$25,000-$50,000) such as hemodialysis, cervical cancer screening, CABG |
| High Risk |
CHD or other vasc. disease (Secondary
Prevention) |
Very favorable cost profile ($3,300-$15,000) similar to BB's
post MI |
|
